Patents by Inventor Xiaowu MA

Xiaowu MA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240068192
    Abstract: An in-situ dynamic settlement test bench and method for the foundation soil is provided. The in-situ dynamic settlement test bench includes a vibration table system, a sensor embedded in the foundation soil, and a water injection trench around the foundation soil. A horizontal vibration load is applied to the lower foundation soil at an in-situ testing site by means of a vibration table, and the dynamic response of the foundation soil is measured through the sensors embedded in different positions, to reflect the seismic settlement deformation of the soil body. Dynamic settlement tests on soils include indoor dynamic simple shear, triaxial and torsional shear tests. A method is proposed for measuring the dynamic response and settlement deformation of the foundation soil by using a vibrator's vibration action on an in-situ soil column. Measurements of the acceleration response and seismic settlement deformation are taken for the foundation soil under in-situ condition.
    Type: Application
    Filed: August 3, 2023
    Publication date: February 29, 2024
    Applicant: Xi’an University of Technology
    Inventors: Shengjun SHAO, Shuai SHAO, Jiang WU, Xiaowu MA
  • Patent number: 11911460
    Abstract: A lipid delivery system, a virus-like structure (VLS) vaccine constructed therefrom, and a lipid particle capable of encapsulating an mRNA molecule encoding a SARS-CoV-2-specific antigen are provided. After the lipid particle encapsulates an mRNA molecule encoding a SARS-CoV-2 antigen, a SARS-CoV-2 S1 antigen protein can be embedded on a surface of an envelope structure of the lipid under specific buffer conditions to produce a VLS vaccine with an antigen-encoding mRNA molecule encapsulated inside and an outer membrane presenting a required viral antigen protein. The vaccine has a superior specific antibody-inducing ability to a SARS-CoV-2 mRNA vaccine and a polypeptide vaccine, can maintain a long-lasting high antibody level, and can also exhibit excellent immune binding abilities for the emerging different variants.
    Type: Grant
    Filed: August 1, 2023
    Date of Patent: February 27, 2024
    Assignees: Weirui Biotechnology (Kunming) Co., LTD., Shandong Weigao Litong Biological Products Co., Ltd.
    Inventors: Qihan Li, Kaili Ma, Yanmei Li, Jingjing Zhang, Lichun Wang, Changyong Mu, Xiaowu Peng, Yanrui Su, Chang'e Liu, Liping He, Lin Feng, Dongxiu Gao, An Wang, Hongbing Li, Gang Xu, Fuyun He, Lichun Zheng, Hongkun Yi